Page last updated: 2024-11-05

glycidyl trimethylammonium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Glycidyl trimethylammonium chloride (GTMA) is a quaternary ammonium compound with a highly reactive epoxide group. It is a colorless to pale yellow liquid that is widely used in the production of polymers, resins, and other chemicals. GTMA is synthesized by reacting epichlorohydrin with trimethylamine. It exhibits a high reactivity due to the presence of both the epoxide ring and the quaternary ammonium group. This makes it a versatile compound with a wide range of applications. GTMA is employed in the synthesis of cationic polymers and resins, which find applications in various fields, including water treatment, adhesives, coatings, and textile finishing. The compound's biocidal properties have also attracted interest for its use in disinfectants and antimicrobial agents. GTMA is a potent biocide against bacteria, fungi, and algae, due to its ability to disrupt cell membranes. Its effects have been extensively studied, and it has been shown to possess cytotoxic effects, particularly against certain cancer cell lines. The importance of GTMA lies in its ability to impart cationic properties and biocidal activity to polymers and materials. This makes it a valuable component in various industrial applications. Researchers are continuously studying GTMA to understand its properties and potential applications in a broader range of fields.'

glycidyl trimethylammonium: causes dermatitis on contact; structure given in first source; RN given refers to chloride [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18205
CHEMBL ID3187272
SCHEMBL ID42703
MeSH IDM0131091

Synonyms (59)

Synonym
.beta.,.gamma.-epoxypropyltrimethylammonium chloride
ammonium,3-epoxypropyl)trimethyl-, chloride
nsc51213
3033-77-0
oxiranemethanaminium,n,n-trimethyl-, chloride
2,3-epoxypropyltrimethylammonium chloride
glycidyltrimethylammonium chloride
n-glycidyl-n,n-trimethylammonium chloride
nsc-51213
1-(trimethylammonio)-2,3-epoxypropane chloride
trimethylglycidylammonium chloride
epoxypropyltrimethylammonium chloride
glytac a 100
n-glycidyl-n,n,n-trimethylammonium chloride
einecs 221-221-0
ccris 4128
beta,gamma-epoxypropyltrimethylammonium chloride
nsc 51213
oxiranemethanaminium, n,n,n-trimethyl-, chloride
ammonium, (2,3-epoxypropyl)trimethyl-, chloride
(2,3-epoxypropyl)trimethylammonium chloride
g-mac
glycidyl-trimethyl-ammonium chloride
n,n,n-trimethyloxiranemethanaminium chloride
glycidyl trimethylammonium
51838-31-4
ec 221-221-0
glycidyl trimethylammonium chloride
unii-283xh39m8x
2-oxiranemethanaminium, n,n,n-trimethyl-, chloride (1:1)
283xh39m8x ,
cas-3033-77-0
tox21_300176
NCGC00254128-01
dtxcid9024643
dtxsid1044643 ,
FT-0634612
2,3-epoxypropyltrimonium chloride [inci]
1,2-epoxy-3-(trimethylammonio)propyl chloride
2,3-epoxypropyltrimonium chloride
(.beta.,.gamma.-epoxypropyl)trimethylammonium chloride
n,n,n-trimethyl(oxiran-2-yl)methanaminium chloride
SCHEMBL42703
PUVAFTRIIUSGLK-UHFFFAOYSA-M
W-109139
AKOS024437790
CHEMBL3187272
mfcd00011940
glycidyltrimethylammonium chloride (ca. 80% in water)
Q2939557
E75838
trimethyl[(oxiran-2-yl)methyl]azanium chloride
n,n,n-trimethyl-1-(oxiran-2-yl)methanaminium chloride
AS-15436
glycidyltrimethylammoniumchloride
trimethyl(oxiran-2-ylmethyl)azanium;chloride
G0476
EN300-244014
SY074803

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The results confirmed the usefulness of this method for characterizing the pharmacokinetic profiles of ACP and its major metabolite M2 in a Phase I pharmacokinetic study."( Direct quantification of anorethidrani disuccinate and determination of sterol metabolites by chemical derivatization combined with LC-MS/MS: Application to a Phase I pharmacokinetic study in humans.
Chen, X; Chen, Y; Jiang, J; Li, L; Lu, Y; Zhong, D, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" Different modification parameters such as chemical dosage and reaction time were tested when using a unique combination of branched polyethylenimine (PEI) and glycidyltrimethylammonium chloride (GTMAC) to produce an aminated biosorbent (termed PG-Peat)."( Production of aminated peat from branched polyethylenimine and glycidyltrimethylammonium chloride for sulphate removal from mining water.
Gogoi, H; Leiviskä, T; Rämö, J; Tanskanen, J, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency9.77000.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (9.09)18.7374
1990's2 (3.64)18.2507
2000's8 (14.55)29.6817
2010's35 (63.64)24.3611
2020's5 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.56 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index44.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.82%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.82%)4.05%
Observational0 (0.00%)0.25%
Other53 (96.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]